CN Patent

CN101141950B — 具有改进的药物代谢动力学特性的药物

Assigned to Bayer Pharma AG · Expires 2011-06-08 · 15y expired

What this patent protects

本发明涉及一种新型伐地那非药物制剂，该药物制剂在口腔中快速崩解，提高生物利用度，并引起平台状的血浆浓度变化过程，及其制备方法。

USPTO Abstract

本发明涉及一种新型伐地那非药物制剂，该药物制剂在口腔中快速崩解，提高生物利用度，并引起平台状的血浆浓度变化过程，及其制备方法。

Drugs covered by this patent

vardenafil-hydrochloride (VARDENAFIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN101141950B
Jurisdiction: CN
Classification: —
Expires: 2011-06-08
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Pharma AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.